HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Štefaniková Selected Research

SU 9516

12/2017Cyclin-dependent kinase 2 inhibitor SU9516 increases sensitivity of colorectal carcinoma cells Caco-2 but not HT29 to BH3 mimetic ABT-737.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Štefaniková Research Topics

Disease

2Neoplasms (Cancer)
12/2017 - 01/2015
1Colorectal Neoplasms (Colorectal Cancer)
12/2017
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2015
1Multiple Myeloma
01/2015

Drug/Important Bio-Agent (IBA)

1ABT-737IBA
12/2017
1Cyclin-Dependent Kinase 2IBA
12/2017
1Apoptosis Regulatory ProteinsIBA
12/2017
1SU 9516IBA
12/2017
1Bortezomib (Velcade)FDA Link
01/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015